This not-to-be-missed two day D4 conference comprises keynote presentations D
Transcription
This not-to-be-missed two day D4 conference comprises keynote presentations D
D4 – DEVICES FOR DIAGNOSTICS AND DRUG DELIVERY 26-27th November 2014 Dunedin, New Zealand This not-to-be-missed two day D4 conference comprises keynote presentations from international and national speakers, covering several major themes. In addition, there is opportunity for a limited number of oral presentations in addition to posters submitted by attendees. The Conference will provide opportunity for networking among registrants who will be coming from industry, research institutes, government agencies and universities, and sharing ideas on the latest developments in devices for diagnostics and drug delivery. D4 Devices Improving the performance of diagnostic devices and combination drug-device products Centre for Bioengineering & Nanomedicine: Professor David Grainger, Dept of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, United States of America Diagnostic Devices Targeted delivery vehicles for in situ diagnosis and screening of early malignancy in the GI tract Professor Abraham Rubinstein, School of Pharmacy Institute for Drug Research, Hebrew University of Jerusalem, Israel Circulating microRNAs as diagnostic and prodiagnostic markets for cardiovascular disease Dr Rajesh Katare, Dept of Physiology, University of Otago, Dunedin, NZ Remote location parasite diagnostics to aid in monitoring anthelmintic drug efficacy Dr Stephen Sowerby, Dept of Biochemistry, University of Otago, Dunedin, NZ TBA Professor Mauro Farella, Dept of Oral Sciences, University of Otago, Dunedin, NZ Devices for Drug Delivery Micro-needle devices for drug, macromolecule and vaccine delivery to and through skin Professor James Birchall School of Pharmacy & Pharmaceutical Sciences, Cardiff University, UK CMDT Magnetic targeting and activation for controlled delivery and release Professor Quentin Pankhurst University College, London, UK Needle-free delivery and diagnosis using fluid jets: capabilities and challenges Associate Professor Andrew Taberner, Auckland Bioengineering Institute, Auckland, NZ Pulmonary delivery of spray-dried powders using dry powder inhalers Dr Shyamal Das, School of Pharmacy, University of Otago, Dunedin, NZ www.bioactives.otago.ac.nz Translation and Its Challenges Regulatory considerations for diagnostics and devices Dr Stewart Jessamine, Medsafe, Wellington, NZ Bringing affordable immunodiagnostics for near-patient care Dr Anand Kumble, Pictor, Auckland, NZ TBA Associate Professor George Dias, Dept of Anatomy, University of Otago, Dunedin, NZ Lessons from US Medtech innovation Chris Somogyi, Callaghan Innovation, Auckland, NZ Submitted paper presentations will also be made in all symposia www.bioactives.otago.ac.nz